Febrile seizures after 2010-2011 trivalent inactivated influenza vaccine

Pediatrics

Volumn 136, Issue 4, 2015, Pages e848-e855

  Kawai, Alison Tse ^a   Martin, David ^b   Kulldorff, Martin ^a   Li, Lingling ^a   Cole, David V ^a   McMahill Walraven, Cheryl N ^c   Selvam, Nandini ^d   Selvan, Mano S ^e   Lee, Grace M ^a,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c AETNA   (United States)

^d HEALTHCORE INC   (United States)

^e HUMANA INC   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PREVENAR13; VACCINE;

AGE DISTRIBUTION; ARTICLE; CHILD; DIPHTHERIA; DISEASE ASSOCIATION; FEBRILE CONVULSION; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; TETANUS; CHEMICALLY INDUCED; FEMALE; MALE; PRESCHOOL CHILD; SEIZURES, FEBRILE;

CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; MALE; PNEUMOCOCCAL VACCINES; RISK FACTORS; SEIZURES, FEBRILE; VACCINES, CONJUGATE;

EID: 84942899266     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-0635     Document Type: Article

References (19)

1. Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM; VSD Rapid Cycle Analysis Influenza Working Group. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine. 2012; 30 (11): 2024-2031
2. Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D. Febrile seizures after 2010-2011 influenza vaccine in young children, United States: A vaccine safety signal from the vaccine adverse event reporting system. Vaccine. 2012; 30 (11): 2020-2023
3. Nguyen M, Ball R, Midthun K, Lieu TA. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: Strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf. 2012; 21 (suppl 1): 291-297
4. Baker MA, Nguyen M, Cole DV, Lee GM, Lieu TA. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization. Vaccine. 2013; 31 (suppl 10): K98-K112
5. Yih WK, Lieu TA, Kulldorff M, et al. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med. 2014; 370 (6): 503-512
6. Greene SK, Kulldorff M, Lewis EM, et al. Near real-time surveillance for influenza vaccine safety: Proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010; 171 (2): 177-188
7. Kramarz P, DeStefano F, Gargiullo PM, et al; Vaccine Safety Datalink Team. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Arch Fam Med. 2000; 9 (7): 617-623
8. Klein NP, Hansen J, Lewis E, et al. Postmarketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization. Pediatr Infect Dis J. 2010; 29 (7): 613-617
9. Rowhani-Rahbar A, Klein NP, Dekker CL, et al; Risk Interval Working Group of the Clinical Immunization Safety Assessment Network. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012; 31 (1): 271-277
10. Baker MA, Lieu TA, Li L, et al. A Vaccine Study Design Selection Framework for the Post-Licensure Rapid Immunization Safety Monitoring Program (PRISM) [published online ahead of print March 13, 2015]. Am J Epidemiol. doi: 10.1093/aje/kwu322
11. Weldeselassie YG, Whitaker HJ, Farrington CP. Use of the self-controlled case-series method in vaccine safety studies: Review and recommendations for best practice. Epidemiol Infect. 2011; 139 (12): 1805-1817
12. Shui IM, Shi P, Dutta-Linn MM, et al; Vaccine Safety Datalink Research Team. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine. 2009; 27 (39): 5307-5312
13. Klein NP, Fireman B, Yih WK, et al; Vaccine Safety Datalink. Measles-mumps-rubellavaricella combination vaccine and the risk of febrile seizures. Pediatrics. 2010; 126 (1). Available at: Www.pediatrics.org/cgi/content/full/126/1/e1
14. Subcommittee on Febrile Seizures; American Academy of Pediatrics. Neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics. 2011; 127 (2): 389-394
15. Huang WT, Gargiullo PM, Broder KR, et al; Vaccine Safety Datalink Team. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics. 2010; 126 (2): 263-269
16. Vestergaard M, Christensen J. Registerbased studies on febrile seizures in Denmark. Brain Dev. 2009; 31 (5): 372-377
17. Manfredini R, Vergine G, Boari B, Faggioli R, Borgna-Pignatti C. Circadian and seasonal variation of first febrile seizures. J Pediatr. 2004; 145 (6): 838-839
18. Grohskopf LA, Olsen SJ, Sokolow LZ, et al; Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) -United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep. 2014; 63 (32): 691-697
19. Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children-use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010; 59 (RR-11): 1-18